Frequently Asked Questions for RFA-HL-10-003 (Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01)

Notice Number: NOT-HL-09-125

Key Dates
Release Date: April 2, 2009

Issued by
National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov)

Purpose

On February 23, 2009, the NHLBI issued a Funding Opportunity Announcements (FOA): RFA-HL-10-003 (Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01) http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-10-003.html.

As a result of discussions with potential applicants, a list of Frequently Asked Questions (FAQs) has been developed.

The FAQs for this FOA can be found at: http://www.nhlbi.nih.gov/funding/inits/faq-phase2.htm. This information may be updated periodically without additional notice.  NHLBI staff will also respond to questions submitted by potential applicants who contact the program, grants management, and review staff listed in the FOA in the Agency Contacts section.

All other aspects of this FOA remain unchanged.

Inquiries

Inquiries should be directed to:

Andrea L. Harabin, Ph.D.
Division of Lung Diseases
National Heart, Lung, and Blood Institute
6701 Rockledge Drive
Bethesda, MD 20892-7952
Telephone: (301) 435-0222
Email: harabina@nhlbi.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.